Amphipathic antimicrobial peptides-from biophysics to therapeutics?

Protein and Peptide Letters

Volumn 17, Issue 11, 2010, Pages 1334-1344

  Dempsey, Christopher E ^a   Hawrani, Ayman ^b,c   Howe, Robin A ^d   Walsh, Timothy R ^c  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Amphipathic helix; Antimicrobial peptide; Magainin; Membrane partitioning; RTA3; Thermodynamics

Indexed keywords

BACTERIA (MICROORGANISMS); MAMMALIA; STREPTOCOCCUS MITIS;

EID: 78650668104     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929866511009011334     Document Type: Article

References (94)

1. Terwilliger, T.C.; Weissman, L.; Eisenberg, D. The structure of melittin in the form I crystals and its implication for melittin's lytic and surface activities. Biophys. J., 1982, 37, 353-361.
2. Segrest, J.P; Jones, M.K; De Loof, H; Brouillette, C.G.; Venka-tachalapathi, Y.V; Anantharamaiah, G.M. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res., 1992, 33, 141-166.
3. Hristova, K.; Wimley, W.C.; Mishra, V.K.; Anantharamaiah, G.M.; Segrest, J.P.; White, S.H. An amphipathic a-helix at a membrane interface: a structural study using a novel x-ray diffraction method. J. Mol. Biol., 1999, 290, 99-117.
4. Hristova, K.; Dempsey, C.E.; White, S.H. Structure, location, and lipid perturbations of melittin at the membrane interface. Biophys. J., 2001, 80, 801-811.
5. Seiler, F.; Malsam, J.; Krause, J.M.; Sollner, T.H. A role of com-plexin-lipid interactions in membrane fusion. FEBS Lett., 2009, 583, 2343-2348.
6. Cardenas, J.; Rivero, S.; Goud, B.; Bornens, M.; Rios, R.M. Golgi localisation of GMAP210 requires two distinct cis-membrane binding mechanisms. BMC Biol., 2009, 7, article #56.
7. Masuda, M.; Takeda, S.; Sone, M.; Ohki, T.; Mori, H.; Kamioka, Y.; Mochizuki, N. Endophilin BAR domain drives membrane curvature by two newly identified structure-based mechanisms. EMBO J., 2006, 25, 2889-2897.
8. Gallop, J.L.; Jao, C.C.; Kent, H.M.; Butler, P.J.G.; Evans, P.R.; Langen, R.; McMahon, H.T. Mechanism of endophilin N-BAR domain mediated membrane curvature EMBO J., 2006, 25, 2898-2910
9. Drin, G.; Casella, J.-F.; Gautier, R.; Boehmer, T.; Schwartz, T.U.; Antonny, B. A general amphipathic α-helical motif for sensing membrane curvature. Nat. Struct. Mol. Biol., 2007, 14, 138-146.
10. Bechinger, B. Rationalizing the membrane interactions of cationic amphipathic antimicrobial peptides by their molecular shape. Curr. Opin. Coll. Interface Sci., 2009, 14, 349-355.
11. Shaw, J.E.; Epand, R.F.; Hsu, J.C.Y.; Mo, G.C.H.; Epand, R.M.; Yip, C.M. Cationic peptide-induced remodelling of model membranes: Direct visualization by in situ atomic force microscopy. J. Struct. Biol., 2008, 162, 121-138.
12. Pohorille, A.; Wilson, M.A.; Chipot, C. Membrane peptides and their role in protobiological evolution. Origins Life Evol. Biospheres, 2003, 33, 173-197.
13. Mulkidjanian, A.Y.; Galperin, M.Y.; Koonin, E.V. Co-evolution of primordial membranes and membrane proteins. Trends. Biochem. Sci., 2009, 34, 206-215.
14. Boman, H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol., 1995, 13, 61-92.
15. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature, 2002, 415, 389-395.
16. Zhang, L.J.; Falla, T.J. Cationic antimicrobial agents-an update. Expert Opin. Invest. Drugs, 2004, 13, 97-106.
17. Jenssen, H.; Hamill, P.; Hancock, R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev., 2006, 19, 491-511.
18. Diamond, G.; Beckloff, N.; Weinberg, A.; Kisich, K.O. The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des., 2009, 15, 2377-2392.
19. Auvynet, C.; Rosenstein, Y. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J., 2009, 276, 6497-6508.
20. Brogden, K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol., 2005, 3, 238-250.
21. Powers, J.P.S.; Martin, M.M.; Goosney, D.L.; Hancock, R.E. The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment. Antimicrob. Agents Che-mother., 2006, 50, 1522-1524.
22. Imura, Y.; Choda, N.; Matsuzaki, K. Magainin 2 in action: distinct modes of membrane permeabilization in living bacterial and mammalian cells. Biophys. J., 2008, 95, 5757-5765.
23. Nicolas, P. Multifunctional host defense peptides: intracellular- targeting antimicrobial peptides. FEBS J., 2009, 276, 6483-6496.
24. Hancock, R.E.W.; Sahl, H.G. Antimicrobial and host-defense pep-tides as new anti-infective therapeutic strategies. Nat. Biotechnol., 2006, 24, 1551-1557.
25. Bechinger, B.; Zasloff, M.; Opella, S.J. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear-magnetic- resonance spectroscopy. Prot. Sci., 1993, 2, 2077-2084.
26. Eisenberg, D.; Weiss, R.M.; Terwilliger, T.C. The helical hydro-phobic moment: a measure of the amphiphilicity of a helix. Nature, 1982, 299, 371-374.
27. Yeaman, M.R.; Yount, N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev., 2003, 55, 27-55.
28. Hurter, P.; Schroter, W.; Schedel, I.; Gercken, G. Phospholipids of red cells and blood plasma in adults, newborn infants, and patients with rh erythroblastosis. Pediatrics, 1970, 46, 259-266.
29. Matsuzaki, K. Control of cell selectivity of antimicrobial peptides. Biochim. Biophys. Acta., 2009, 1788, 1687-1692.
30. McInnes, C.; Kondejewski, L.H.; Hodges, R.S.; Sykes, B.D. Development of the structural basis for antimicrobial and hemolytic activities of peptides based on gramicidin S and design of novel analogs using NMR spectroscopy. J. Biol. Chem., 2000, 275, 14287-14294.
31. Chen, Y.; Mant, C.T.; Farmer, S.W.; Hancock, R.E.; Vasil, M.L.; Hodges, R.S. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem., 2005, 280, 12316-12329.
32. Hawrani, A.; Howe, R.A.; Walsh, T.R.; Dempsey, C.E. Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides. J. Biol. Chem., 2008, 283, 18636-18645.
33. Pasupuleti, M.; Walse, B.; Svensson, B.; Malmsten, M.; Schmidtchen, A. Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry, 2008, 47, 9057-9070.
34. Nan, Y.H.; Bang, J.K.; Shin, S.Y. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity. Peptides, 2009, 30, 832-838.
35. Connolly, M.L. Solvent-accessible surfaces of proteins and nucleic-acids. Science, 1983, 227, 709-713.
36. Huang, J.-F.; Xu, Y.-M.; Hao, D.-M.; Huang, Y.-B.; Liu, Y.; Chen, Y. Structure-guided de novo design of a-helical antimicrobial peptide with enhanced specificity. Pure Appl. Chem., 2010, 82, 243-257.
37. Wall, J.; Golding, C.A.; van Veen, M.; O'Shea, P. The use of fluo-resceinphosphatidylethanolamine (FPE) as a real-time probe for peptide membrane interactions. Mol. Membr. Biol., 1995, 72, 183-192.
38. Wolfenden, R. Experimental measures of amino acid hydrophobic-ity and the topology of transmembrane and globular proteins. J. Gen. Physiol., 2007, 729, 357-362.
39. MacCallum, J.L.; Bennett, W.F.D.; Tieleman, D.P. Partitioning of amino acid side chains into lipid bilayers: Results from computer simulations and comparison to experiment. J. Gen. Physiol., 2007, 729, 371-377.
40. Rathinakumar, R.; Wimley, W.C. Biomolecular engineering by combinatorial design and high-throughput screening: Small, soluble peptides that permeabilize membranes. J. Am. Chem. Soc., 2008, 730, 9849-9858.
41. Rathinakumar, R.; Walkenhorst, W.F.; Wimley, W.C. Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: The importance of interfacial activity. J. Am. Chem. Soc., 2009, 737, 7609-7617.
42. Dathe, M.; Schumann, M.; Wieprecht, T.; Winkler, A.; Beyermann, M.; Krause, E.; Matsuzaki, K.; Murase, O.; Bienert, M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry, 1996, 35, 12612-12622.
43. Giangaspero, A.; Sandri, L.; Tossi, A. Amphipathic alpha helical antimicrobial peptides-A systematic study of the effects of structural and physical properties on biological activity. Eur. J. Biochem., 2001, 268, 5589-5600.
44. Zelezetsky, I.; Pacor, S.; Pag, U.; Papo, N.; Shai, Y.; Sahl, H.G.; Tossi, A. Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem. J., 2005, 390, 177-188.
45. Mason, A. J.; Moussaoui, W.; Abdelrahman, T.; Boukhari, A.; Bertani, P.; Marquette, A.; Shooshtarizaheh, P.; Moulay, G.; Boehm, N.; Guerold, B.; Sawers, R.J.H.; Kichler, A.; Metz-Boutigue, M.-H.; Candolfi, E.; Prevost, G.; Bechinger, B. Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. J. Biol. Chem., 2009, 284, 119-133.
46. Wieprecht, T.; Apostolov, O.; Beyermann, M.; Seelig, J. Thermodynamics of the α-helix-coil transition of amphipathic peptides in a membrane environment: Implications for peptide-membrane binding equilibrium. J. Mol. Biol., 1999, 294, 785-794.
47. Ladokhin, A.S.; White, S.H. Folding of amphipathic a-helices on membranes: Energetics of helix formation by melittin. J. Mol. Biol., 1999, 285, 1363-1369.
48. Wimley, W.C.; White, S.H. Experimentally determined hydropho-bicity scale for proteins at membrane interfaces. Nat. Struct. Biol., 1996, 3, 842-848.
49. Snider, C; Jayasinghe, S.; Hristova, K.; White, S.H. MPEx: A tool for exploring membrane proteins. Prot. Sci., 2009, 78, 2624-2628.
50. Fernandez-Vidal, M.; Jayasinghe, S.; Ladokhin A.S.; White S.H. Folding amphipathic helices into membranes: amphiphilicity trumps hydrophobicity. J. Mol. Biol., 2007, 370, 459-470.
51. Hessa, T.; Kim, H.; Bihlmaier, K.; Lundin, C.; Boekel, J.; Andersson, H.; Nilsson, I.; White, S.H.; von Heijne, G. Recognition of transmembrane helices by the endoplasmic reticulum translocon. Nature, 2005, 433, 377-381.
52. Ladokhin, A.S.; White, S.H. Protein chemistry at membrane interfaces: non-additivity of electrostatic and hydrophobic interactions. J. Mol. Biol. 2001, 309, 543-552.
53. Hawrani, A.; Howe, R.A.; Walsh, T.R.; Dempsey, C.E. Thermodynamics of RTA3 peptide binding to membranes and consequences for antimicrobial activity. Biochim. Biophys. Acta, 2010, 1798, 1254-1262.
54. Brasseur, R.; Vandenbranden, M.; Cornet, B.; Burny, A.; Ruysschaert, J. Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins. Biochim. Biophys. Acta, 1990, 1029, 267-273.
55. Harris, F.; Daman, A.; Wallace, J.; Dennison, S.R.; Phoenix, D.A. Oblique orientated α-helices and their prediction. Curr. Protein Pept. Sci., 2006, 7, 529-537.
56. Bradshaw, J.P.; Darkes, M.J.M.; Harroun, T.A.; Katsaras, J.; Epand, R.M. Oblique membrane insertion of viral fusion peptide probed by neutron diffractions. Biochemistry, 2000, 39, 6581-6585.
57. Thomas, L.; Scheidt, H.A.; Bettio, A.; Beck-Sickinger, A.G.; Huster , D.; Zschornig, O. The interaction of neuropeptide Y with negatively charged and zwitterionic phospholipid membranes. Eur. Biophys. J., 2009, 38, 663-677.
58. Strömstedt, A.A.; Wessman, P.; Ringstad, L.; Edwards, K.; Malm-sten, M. Effect of lipid headgroup composition on the interaction between melittin and lipid bilayers. J. Colloid Interface Sci., 2007, 311, 59-69.
59. Asthana, N.; Yadav, S.P.; Ghosh, J.K. Dissection of antibacterial and toxic activity of melittin. A leucine zipper motif plays a crucial role in determining its haemolytic activity but not antibacterial activity. J. Biol. Chem., 2004, 279, 55042-55050.
60. Andersen, O.S. Perspectives on membrane protein insertion, pro-tein-bilayer interactions, and amino acid side chain hydrophobicity. J. Gen. Physiol., 2007, 129, 351-352.
61. Dorairaj, S; Allen, T.W. On the thermodynamic stability of a charged arginine side chain in a transmembrane helix. Proc. Natl. Acad. Sci. USA, 2007, 104, 4943-4948
62. Matyus, E.; Kandt, C.; Tieleman, D.P. Computer simulation of antimicrobial peptides. Curr. Med. Chem., 2007, 14, 2789-2798.
63. Wee, C.L.; Ulmschneider, M.B.; Sansom, M.S.P. Membrane/toxin interaction energetics via serial multiscale molecular dynamics simulations. J. Chem. Theor. Comput., 2010, 6, 966-976.
64. Rex, S.; Schwarz, G. Quantitative studies on the melittin-induced leakage mechanism. Biochemistry, 1998, 37, 2336-2345.
65. Wieprecht, T.; Dathe, M.; Beyermann, M.; Krause, E.; Maloy, W.L.; MacDonald, D.L.; Bienert, M. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry, 1997, 36, 6124-6132.
66. Wenk, M.R.; Seelig, J. Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation. Biochemistry, 1998, 37, 3909-3916.
67. Dempsey, C.E.; Ueno, S.; Avison, M.B. Enhanced membrane per-meabilization and antibacterial activity of a disulfide-dimerized magainin analogue. Biochemistry, 2003, 42, 402-409.
68. Matsuzaki, K.; Sugishita, K.; Ishibe, N.; Ueha, M.; Nakata, S.; Miyajima, K.; Epand, R.M. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry, 1998, 37, 11856-11863.
69. Matsuzaki, K.; Murase, O.; Tokuda, H.; Funakoshi, S.; Fujii, N.; Miyajima, K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry, 1994, 33, 3342-3349.
70. Matsuzaki, K.; Murase, O.; Miyajima, K. Kinetics of pore formation by an antimicrobial peptide, magainin-2, in phospholipid-bilayers. Biochemistry, 1995, 34, 12553-12559.
71. Takei, J.; Remenyi, A.; Dempsey, C.E. Generalised bilayer perturbation from peptide helix dimerisation at membrane surfaces: vesicle lysis induced by disulphide-dimerised melittin analogues. FEBS Lett., 1999, 442, 11-14.
72. Wu, Y.; He, K.; Ludtke, S.J.; Huang, H.W. X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytanoyl phosphatidylcholine with alamethicin at low concentrations. Biophys. J., 1995, 68, 2361-2369.
73. Zemel, A.; Ben-Shaul, A.; May, S. Perturbation of a lipid membrane by amphipathic peptides and its role in pore formation. Eur. Biophys. J., 2005, 34, 230-242.
74. Huang, H.W. Free energies of molecular bound states in lipid bi-layers: Lethal concentrations of antimicrobial peptides. Biophys. J., 2009, 96, 3263-3272.
75. Bechinger, B. Structure and function of membrane-lytic peptides. Crit. Rev. Plant Sci.., 2004, 23, 271-292.
76. Lohner, K.; Blondelle, S.E. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Combinator. Chem. High Throughput Screen., 2005, 8, 241-256.
77. Huang, H.W. Molecular mechanism of antimicrobial peptides: The origin of cooperativity. Biochim. Biophys. Acta, 2006, 1758, 1292-1302
78. Andersson, A.; Danielsson, J.; Graslund, A.; Maler, L. Kinetic models for peptide-induced leakage from vesicles and cells. Eur. Biophys. J., 2007, 36, 621-635.
79. Gregory, S.M.; Pokorny, A.; Almeida, P.F.F. Magainin 2 revisited: A test of the quantitative model for the all-or-nothing permeabilization of phospholipid vesicles. Biophys. J., 2009, 96, 116-131.
80. Almeida, P.F.F.; Pokorny, A. Mechanisms of antimicrobial, cyto-lytic, and cell-penetrating peptides: From kinetics to thermodynamics. Biochemistry, 2009, 48, 8083-8093.
81. Leontiadou, H.; Mark, A.E.; Marrink, S. J. Antimicrobial peptides in action. J. Am. Chem. Soc., 2006, 128, 12156-12161.
82. Sengupta, D., Leontiadou, H., Mark, A.E. and Marrink, S.-J. Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim. Biophys. Acta, 2008, 1778, 2308-2317.
83. Tamba, Y.; Yamazaki, M. Single giant unilamellar vesicle method reveals effect of antimicrobial peptide magainin 2 on membrane permeability. Biochemistry, 2005, 44, 15823-15833.
84. Mally, M.; Majhenc, J.; Svetina, S.; Zeks, B. The response of giant phospholipid vesicles to pore-forming peptide melittin. Biochim. Biophys. Acta., 2007, 1768, 1179-1189.
85. Lee, M.T.; Hung, W.C.; Chen, F.Y.; Huang, H.W. Mechanism and kinetics of pore formation in membranes by water-soluble amphipathic peptides. Proc. Natl. Acad. Sci. USA, 2008, 705, 5087-5092.
86. Bradshaw, J.P. Cationic antimicrobial peptides-Issues for potential clinical use. Biodrugs, 2003, 17, 233-240.
87. Marr, A.K.; Gooderham, W.J.; Hancock, R.E.W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol., 2006, 6, 468-472.
88. Page, M.G.P.; Heim, J. Prospects for the next anti-Pseudomonas drug. Curr. Opin. Pharmacol., 2009, 9, 558-565.
89. Vaara, M. New approaches in peptide antibiotics. Curr. Opin. Pharmacol., 2009, 9, 571-576.
90. Li, J.; Nation, R.L.; Turnidge, J.D.; Milne, R.W.; Coulthard, K.; Rayner, C.R; Paterson, D.L. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis., 2006, 6, 589-601. \
91. Bergen, P.J.; Li, J.; Rayner, C.R.; Nation, R.L. Colistin methano-sulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 2006, 50, 1952-1958.
92. Chongsiriwatana, N.P.; Patch, J.A.; Czyzewski, A.M.; Dohm, M.T.; Ivankin, A.; Gidalevitz, D.; Zuckermann, R.N.; Barron, A.E. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. USA, 2008, 105, 2794-2799.
93. Choi, S.; Isaacs, A.; Clements, D.; Liu, D. H.; Kim, H.; Scott, R.W.; Winkler, J.D.; DeGrado, W.F. De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers Proc. Natl. Acad. Sci. USA, 2009, 106, 6968-6973.
94. Fischbach, M.A.; Walsh, C.T. Antibiotics for emerging pathogens. Science 2009, 325, 1089-1093.